The role of angiotensin-converting enzyme gene polymorphism in pulmonary thromboembolism [5]

Thrombosis and Haemostasis

Volumn 92, Issue 2, 2004, Pages 432-433

  Ekim, Numan ^a,c   Oguzulgen, I Kivilcim ^a   Demir, Nalan ^a   Altinok, Buket ^b   Akar, Nejat ^b  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c Dept of Paediatric Molec Genetics ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; PROTHROMBIN;

ADULT; AGED; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LETTER; LUNG EMBOLISM; LUNG PERFUSION; LUNG SCINTISCANNING; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RECURRENCE RISK; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL ANALYSIS;

EID: 4444239430     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613735     Document Type: Letter

References (14)

1. Koppel H, Renner W, Gugl A, et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis. Thromb Haemost 2004; 91: 76-9.
2. Akar N, Aras Ö, Ömürlü K, et al. Deletion polymorphism at the angiotensinogen converting enzyme gene in Turkish patients with coronary artery disease and controls. Scand J Clin Lab Invest 1998; 58: 491-5.
3. Akar N. Site specific mutagenesis: Usage for the mutation detection in thrombosis. Turk J Haematol 1998; 15: 123-4.
4. Rigat N, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
5. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994; 46: 94-101.
6. Cody RJ. The integrated effects of angiotensin II. Am J Cardiol 1997; 78: 297-301.
7. Wells PS, Rodger MA, Forgie MA, et al. The ACE D/D genotype is protective against the development of idiopathic deep vein thrombosis and pulmonary embolism. Thromb Haemost 2003; 90: 829-34.
8. Von Depka M, Czwalinna A, Wermes C, et al. The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 2003; 89: 847-52.
9. Della Valle CJ, Issack PS, Baitner A, et al. The relationship of the factor V Leiden mutation or the deletion-deletion polymorphism of the angiotensin converting enzyme to postoperative thromboembolic events following total joint artroplasty. BMC Musculoskelet Disord 2001; 2: 1.
10. Lu Y, Hui R, Zhao Y. Insertion/deletion polymorphism of the angiotensin I converting enzyme gene and pulmonary thromboembolism in Chinese population. Zhonghua Jie He He Hu Xi Za Zhi 2001; 24: 265-8.
11. Jackson A, Brown K, Langdown J, et al. Effect of the angiotensin-converting enzyme gene deletion polymorphism on the risk of venous thromboembolism. Br J Haematol 2000; 111: 562-4.
12. Gonzalez Ordonez AJ, Fernandez Carreira JM, Medina Rodriguez JM, et al. Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene. Blood Coagul Fibrinolysis 2000; 11: 485-90.
13. Philipp CS, Dilley A, Saidi P, et al. Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty. Thromb Haemost 1998; 80: 869-73.
14. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998; 147: 30-5.